Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 29, Number 1—January 2023
Dispatch

Burden of Postinfectious Symptoms after Acute Dengue, Vietnam

Dong Thi Hoai Tam1, Hannah Clapham1Comments to Author , Elisabeth Giger, Nguyen Tan Thanh Kieu, Nguyen Tran Nam, Dinh Thi Tri Hong, Banh Thi Nuoi, Nguyen Thi Hong Cam, Nguyen Than Ha Quyen, Hugo C. Turner, Thomas Jaenisch, Cameron P. Simmons, Phung Khanh Lam, and Bridget Wills
Author affiliations: Oxford University Clinical Research Unit, Wellcome Trust Asia Programme, Ho Chi Minh City, Vietnam (D.T.H. Tam, E. Giger, N.T.T. Kieu, D.T.T. Hong, B.T. Nuoi, N.T.H. Cam, N.T.H. Quyen, P.K. Lam, B. Wills); University of Oxford, Oxford, England, UK (H. Clapham, B. Wills); National University of Singapore and National University Health System, Singapore (H. Clapham); City Children’s Hospital, Ho Chi Minh City (N.T. Nam); Imperial College London, London, England, UK (H.C. Turner); Heidelberg University Hospital, Heidelberg, Germany (T. Jaenisch); Colorado School of Public Health, Aurora, Colorado, USA (T. Jaenisch); Monash University, Melbourne, Victoria, Australia (C.P. Simmons); University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City (K. Lam)

Main Article

Table

Number and percentage estimates of persons experiencing postacute symptoms after dengue or other febrile illness during the 3-month follow-up period, Vietnam

Symptom Other febrile illness, n = 47
 Dengue, n = 200
No. % (95% CI) No. % (95% CI)
Alopecia 2 4.3 (0.5–14.5) 25 12.5 (8.3–17.9)
Tiredness 4 8.5 (2.4–20.4) 17 8.5 (5.0–13.3)
Resumed daily activities 47 100 (92.5–100) 200 100 (98.2–100)
Headaches 3 6.4 (1.3–17.5) 6 3.0 (1.1–6.4)
Muscle pain 0 0 (0.0–7.6) 3 1.5 (0.3–4.3)
Joint pain 2 4.3 (0.5–14.5) 3 1.5 (0.3–4.2)
Loss of appetite 2 4.3 (0.5–14.5) 3 1.5 (0.3–4.3)
Blurred vision 9 19.1 (9.2–33.3) 22 11.1 (7.0–16.2)
Rash 3 6.4 (1.3–17.5) 21 10.5 (6.6–15.6)
Sleep problem 2 4.3 (0.5–14.5) 9 4.5 (2.1–8.4)
Concentration problem 6 12.3 (4.8–25.7) 19 9.5 (5.8–14.4)
Little interest 1 2.1 (0.1–11.3) 1 0.5 (0.0–2.8)
Depressed 0 0 (0.0–7.6) 0 0 (0.0–1.8)
Other problems, including alopecia 3 6.4 (1.3–17.5) 32 16.0 (11.2–21.8)
Any symptom 22 47 (32.0–62.0) 92 46 (39.0–53.0)
Other acute illness 14 29.8 (17.3–44.9) 33 16.5 (11.6–22.4)

Main Article

1These first authors contributed equally to this article.

Page created: November 17, 2022
Page updated: December 22, 2022
Page reviewed: December 22, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external